Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.

Abstract

The growing heart failure population and the benefit of revascularization in patients with severe LV dysfunction have led to an increase in the number of mechanically assisted percutaneous coronary interventions. Circulatory support with the Impella LP 2.5 pump during high risk PCI is feasible, but larger studies are required to demonstrate its efficacy in these severely compromised and vulnerable patients.